by IR Team | Jun 3, 2019 | Press Release
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has signed a cannabinoid product supply...
